微创美容市场：现况分析及预测（2024-2032）

由于产品推出数量的增加，微创美容市场预计将稳定成长约9.5%。例如，Aesthetic Management Partners (AMP) 于 2024 年 2 月推出了 Plasmage。Plasmage是首款提供精确控制的等离子分数非侵入性美容设备，可安全地解决各种皮肤病问题，如脸部和身体皱纹、娇嫩皮肤、黄斑病、皮赘、肌瘤等。有几个因素正在推动预测期内的市场成长，例如微创美容手术的应用领域不断扩大。除此之外，微创整容手术的可负担性和可及性的提高也在稳步推动这个市场。

依产品划分，市场分为肉毒桿菌、软组织填充剂、化学换肤、雷射除毛、微晶磨皮等。预计肉毒毒素细分市场在预测期内将以显着的复合年增长率成长。肉毒桿菌毒素，通常称为 Botox、Dysport 或 Xeomin，是全球使用最广泛的微创美容疗程之一。肉毒桿菌会暂时阻断肌肉的神经讯号，防止肌肉收缩。透过抑制肌肉运动，它可以软化皱纹和细纹，使外观更光滑、更年轻。肉毒桿菌毒素因其有效性、最少的恢復时间和自然的效果而越来越受欢迎。例如，2021 年 7 月发表在 Pubmed Central 上的一项伊朗两个皮肤科中心的横断面研究发现，61.3% 的参与者要求注射肉毒桿菌毒素。因此，在这些产品中，肉毒桿菌毒素预计在预测期内将以显着的复合年增长率成长。

根据应用，市场分为痤疮、创伤性疤痕、色素沉着、脂肪组织再生等。2023年，痤疮细分市场占据主导地位。市场上的痤疮细分市场响应了对非手术治疗来控制痤疮和改善皮肤外观不断增长的需求。这些治疗通常包括多种旨在缩小痤疮病变、改善皮肤纹理和最大限度减少痤疮相关疤痕的治疗方法。市场上的痤疮细分市场提供了多种有效的治疗方法来控制痤疮和改善皮肤外观，迎合了寻求非手术解决痤疮相关问题的人们日益增长的趋势。例如，根据美国皮肤病学会的数据，痤疮是美国最常见的皮肤病，每年影响 5,000 万美国人。因此，从应用来看，2023年痤疮领域将占据较大的市场占有率。

根据最终用户，市场分为医院、皮肤科诊所等。由于美容护理需求不断增长，皮肤科诊所领域预计在预测期内将以显着的复合年增长率增长。例如，以色列 Super-Pharm 的 "Beauty Clinic" 连锁店将于 2024 年 3 月在其现有的 5 家占地 140 平方米的诊所之外，在Bat Yam的 Sea Park 开设一家新店。许多皮肤科诊所提供全面的美容手术，包括微创美容手术以及医学皮肤科服务。皮肤科医师根据每位患者的皮肤状况、美感目标和偏好制定客製化的治疗计画。皮肤科医生和诊所工作人员向患者宣传治疗的益处、期望和潜在风险，以便患者能够就治疗做出明智的决定。因此，皮肤科诊所类别预计在预测期内将以显着的复合年增长率增长。

为了更瞭解微创美容手术的市场介绍，市场分为北美（美国、加拿大等北美地区）、欧洲（德国、英国、法国、西班牙、义大利等欧洲地区）和亚太地区（中国、日本）、印度、世界其他地区（亚太地区）和世界其他地区。由于技术进步、产品发布增加和企业联盟增加，北美在 2023 年目前的情况下占据市场主导地位。例如，2023 年 9 月，专有宽平台技术和健康公司 Avenir Wellness Solutions, Inc. 的子公司 Sera Labs, Inc. 与着名整形外科医生 Michael A. Persky 博士合作，协助行销该产品。以及新产品创新的建议。越来越多地采用非侵入性手术、提高负担能力和可用性正在推动该地区的市场成长。因此，依地区划分，北美将在 2023 年占据较大市场占有率。

市场上的一些主要参与者包括 AbbVie Inc.、DiamondTome Pro.、SILHOUET-TONE、DermMedica、Venus Concept、Quanta System、Lynton Lasers Ltd.、Sciton、Sisram Medical Ltd.、Lumenis Be Ltd.。

目录

第1章 市场介绍

• 市场定义
• 主要目标
• 利益相关者
• 限制

第2章 研究方法或前提条件

• 调查过程
• 调查方法
• 受访者简介

第3章 市场总结

第4章 执行摘要

第5章 COVID-19对微创整容市场的影响

第6章 2022-2032年微创美容市场收入

第7章 市场分析：依产品分类

• 肉毒桿菌毒素
• 软组织填充剂
• 化学换肤
• 雷射除毛
• 微晶磨皮术
• 其他

第8章 市场分析：依应用分类

• 粉刺
• 外伤疤痕
• 色素沉着
• 脂肪组织再生
• 其他

第9章 市场分析：依最终用户

• 医院
• 皮肤科诊所
• 其他

第10章 市场分析：依地区

• 北美
  • 美国
  • 加拿大
  • 其他北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 亚太其他地区
• 世界其他地区

第11章 微创美容市场动态

• 市场驱动力
• 市场课题
• 影响分析

第12章 微创美容市场机会

第13章 微创美容市场趋势

第14章 需求面和供给面分析

• 需求面分析
• 供给侧分析

第15章 价值链分析

第16章 竞争场景

• 竞争格局
  • 波特五力分析

第17章 公司简介

• AbbVie Inc.
• DiamondTome Pro.
• SILHOUET-TONE
• DermMedica
• Venus Concept
• Quanta System
• Lynton Lasers Ltd
• Sciton
• Sisram Medical Ltd
• Lumenis Be Ltd.

第18章 免责声明

Minimally invasive cosmetic procedures are non-surgical treatments aimed at enhancing one's appearance with minimal downtime and discomfort. These procedures typically involve injections, laser therapy, or other non-invasive techniques to address concerns such as wrinkles, fine lines, volume loss, and skin texture irregularities. They offer a less invasive alternative to traditional surgical procedures while still achieving noticeable improvements in appearance. The increasing adoption of minimally invasive procedures has led to the market's growth. Several other factors, such as minimal downtime, reduced risk, rising technological advancements, and a surge in company collaborations & partnerships, are driving the minimally invasive cosmetic procedures market globally.

The Minimally Invasive Cosmetic Procedures Market is expected to grow at a steady rate of around 9.5% owing to the rising number of product launches. For instance, in February 2024, Aesthetic Management Partners (AMP) launched Plasmage - the first fractional plasma non-invasive aesthetic device providing precise control to the provider to safely address crepey skin, wrinkles, and delicate skin on the face and body as well as a variety of dermatological issues such as Xanthelasma, skin tags, and fibromas. Several factors, including the expanding application areas of minimally invasive cosmetic procedures, are driving the market's growth during the forecast period. Apart from this, improving affordability and accessibility of minimally invasive cosmetic procedures are also driving this market at a steady rate.

Based on the product, the market is segmented into botulinum toxins, soft tissue fillers, chemical peel, laser hair removal, microdermabrasion, and others. The botulinum toxins segment is expected to grow with a significant CAGR in the forecast period. Botulinum toxins, commonly called Botox, Dysport, or Xeomin are among the most widely used minimally invasive cosmetic treatments globally. Botulinum toxins temporarily block nerve signals to the muscles, preventing them from contracting. By inhibiting muscle movement, wrinkles and lines are softened, leading to a smoother and more youthful appearance. The popularity of botulinum toxin is rising owing to their effectiveness, minimal downtime, and natural-looking results. For instance, according to a cross-sectional study in two Iranian dermatology centers published in Pubmed Central in July 2021, 61.3% of participants asked for botulinum toxin injections. Thus, among the products, the botulinum toxins are expected to grow with a significant CAGR in the forecast period.

Based on the application, the market is segmented into acne, trauma scars, hyperpigmentation, adipose tissue regeneration, and others. The acne segment dominated the market in the year 2023. The acne segment within the market addresses the growing demand for non-surgical treatments to manage acne and improve skin appearance. These treatments typically include a variety of treatments aimed at reducing acne lesions, improving skin texture, and minimizing acne-related scarring. The acne segment within the market offers a range of effective treatments for managing acne and improving skin appearance, catering to the needs of the rising number of individuals seeking non-surgical solutions for acne-related concerns. For instance, according to the American Academy of Dermatology, acne is the most common skin condition in the U.S., affecting up to 50 million Americans annually. Thus, among the applications, the acne segment held a significant market share in 2023.

Based on the end user, the market is segmented into hospitals, dermatology clinics, and others. The dermatology clinics segment is expected to grow with a significant CAGR in the forecast period owing to the growing demand for aesthetic care. For instance, in March 2024, Israel-based Super-Pharm's 'Beauty Clinic' chain launched its 6th Branch, a new branch in Bat Yam's Sea Park, joining five existing clinics spanning 140 square meters. Many dermatology clinics offer a comprehensive range of aesthetic procedures, including minimally invasive cosmetic procedures, alongside medical dermatology services. Dermatologists develop customized treatment plans tailored to each patient's unique skin condition, aesthetic goals, and preferences. Dermatologists and clinic staff educate patients about the benefits, expectations, and potential risks of the treatments, empowering them to make informed decisions about their care. Thus, the dermatology clinics category is expected to grow with a significant CAGR in the forecast period.

For a better understanding of the market adoption of minimally invasive cosmetic procedures, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2023 due to the advancements in technology, rising product launches, and rising company collaborations. For instance, in September 2023, Sera Labs, Inc. a subsidiary of Avenir Wellness Solutions, Inc. a proprietary broad platform technology and wellness company, collaborated with renowned plastic surgeon Dr. Michael A. Persky, who will help support marketing for the brand's latest launches and advise on new product innovation. Other factors such as the rising adoption of non-invasive procedures and improving affordability and accessibility are propelling the growth of the market in the region. Thus, amongst regions, North America held a significant share of the market in 2023.

Some of the major players operating in the market include AbbVie Inc., DiamondTome Pro.; SILHOUET-TONE, DermMedica, Venus Concept, Quanta System, Lynton Lasers Ltd, Sciton, Sisram Medical Ltd, Lumenis Be Ltd.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Minimally Invasive Cosmetic Procedures Market
• 2.2. Research Methodology of the Minimally Invasive Cosmetic Procedures Market
• 2.3. Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.IMPACT OF COVID-19 ON THE MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET

6.MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET REVENUE (USD BN), 2022-2032F

7.MARKET SEGMENT BY PRODUCT

• 7.1. Botulinum Toxins
• 7.2. Soft Tissue Fillers
• 7.3. Chemical Peel
• 7.4. Laser Hair Removal
• 7.5. Microdermabrasion
• 7.6. Others

8.MARKET SEGMENT BY APPLICATION

• 8.1. Acne
• 8.2. Trauma Scars
• 8.3. Hyperpigmentation
• 8.4. Adipose Tissue Regeneration
• 8.5. Others

9.MARKET SEGMENTATION BY END-USER

• 9.1. Hospitals
• 9.2. Dermatology Clinics
• 9.3. Others

10.MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11.MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12.MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET OPPORTUNITIES

13.MINIMALLY INVASIVE COSMETIC PROCEDURES MARKET TRENDS

14.DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15.VALUE CHAIN ANALYSIS

16.COMPETITIVE SCENARIO

• 16.1. Competitive Landscape
  • 16.1.1. Porters Five Forces Analysis

17.COMPANY PROFILED

• 17.1. AbbVie Inc.
• 17.2. DiamondTome Pro.
• 17.3. SILHOUET-TONE
• 17.4. DermMedica
• 17.5. Venus Concept
• 17.6. Quanta System
• 17.7. Lynton Lasers Ltd
• 17.8. Sciton
• 17.9. Sisram Medical Ltd
• 17.10. Lumenis Be Ltd.

18.DISCLAIMER